Registered entities
Innovation
16 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 469 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 11 |
| 2026 | 5 |
Social engagement
Social engagement: 9.8K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
16 investors on record; lead investors include Foresite Capital, Samsara BioCapital, VenBio, General Atlantic.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 56% |
| Private equity | 3 | 19% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 3 | 19% |
Hiring activity
Hires periodically
6 roles tracked across 4 of the last 12 months
7 May 2026 · Vice President Corporate Communications & Investor Relations · South San Francisco
10 Mar 2026 · Data Systems & Clinical Programming Specialist (Contractor) · South San Francisco
9 Mar 2026 · Senior Clinical Development (Medical Director), Dermatology · South San Francisco
14 Jan 2026 · Director, Statistical Programming · South San Francisco
24 Oct 2025 · Senior Director, Business Insights and Analytics · South San Francisco
Based on job postings tracked across public sources.